Cannabinoids Guide
CBD and THC are the two best-known cannabinoids found in the Cannabis sativa L. plant. They are often mentioned together, sometimes confused, despite having major differences. CBD, or cannabidiol, is primarily known for not producing a psychoactive effect. THC, or delta-9-tetrahydrocannabinol, is the molecule responsible for the euphoric and intoxicating effects associated with THC-rich cannabis.
Understanding the difference between CBD and THC is essential to avoid confusion, better read labels, understand the legal framework in France and Europe, identify the risks of drug testing, distinguish between wellness and intoxicating use, and promote responsible cannabidiol use. A compliant CBD product should not be equated with a THC-rich product, but neither should it be presented as completely free of potential risks.
This article provides a comprehensive analysis of the differences between CBD and THC: botanical origin, structure, effects, interaction with the endocannabinoid system, legal status, THC threshold, driving, laboratory analyses, precautions, and common mistakes. This is informational content, not medical advice, and is not intended to be a sales pitch.
CBD and THC: simple definitions
CBD and THC belong to the same family of molecules: cannabinoids. These compounds are naturally present in the hemp or cannabis plant. However, their profiles are very different. CBD does not produce the "high" associated with THC-rich cannabis. THC, on the other hand, has a psychotropic effect, meaning it can alter consciousness, perception, mood, alertness, and certain cognitive functions.
Definition of CBD
CBD is short for cannabidiol. It is a cannabinoid naturally present in Cannabis sativa L. It can be extracted from hemp and incorporated into various types of products, within a specific regulatory framework. CBD is often studied for its interactions with the endocannabinoid system, but it should not be presented as a medicine in content intended for the general public.
For a complete definition, see:
CBD: scientific definition of cannabidiol.
Definition of THC
THC primarily refers to delta-9-tetrahydrocannabinol. It is the cannabinoid best known for its psychotropic effects. It can cause a feeling of euphoria, altered perception, impaired alertness, and decreased psychomotor abilities. This property explains its strict regulation.
The difference between CBD and THC is therefore not simply a matter of name. It concerns the effects, regulations, precautions, the risks of detection, and how the products should be presented to the public.
CBD and THC: a common botanical origin
CBD and THC both come from Cannabis sativa L. This common origin explains why the two molecules are often confused. However, not all varieties of Cannabis sativa L. have the same profile. Some are selected for their low THC content and their industrial or wellness uses. Others are associated with a higher THC content and strictly regulated use.
In everyday language, a distinction is often made between hemp and cannabis. Hemp generally refers to low-THC varieties used for fibers, seeds, vegetable oil, materials, cosmetics, or certain compliant CBD products. Cannabis is often associated with high-THC varieties. This distinction is useful, but it must remain precise: botanically, they are closely related plants, the main difference being often chemical and regulatory.
To delve deeper into this distinction, see:
Hemp, cannabis, CBD and THC: understanding the differences.
The concept of chemotype
The chemotype refers to the chemical profile of a plant. Two plants can belong to the same botanical species but produce very different proportions of cannabinoids. Some varieties are naturally richer in CBD, others richer in THC, and still others may contain more CBG or other compounds.
For consumers, this concept is important: a product's conformity depends not only on its appearance or smell, but also on its actual composition. Only testing can accurately verify the levels of CBD, THC, and other cannabinoids.
Chemical structure: why don't CBD and THC act the same way?
CBD and THC have a similar molecular formula, but their three-dimensional structure and how they interact with biological receptors differ. This difference explains why two molecules from the same plant can produce very different effects.
THC acts primarily on CB1 receptors of the endocannabinoid system. These receptors are particularly abundant in the central nervous system. Their activation by THC can lead to psychotropic effects. CBD, on the other hand, does not act as a direct activator of CB1. It appears to have a more indirect and modulating action.
A difference in action, not just a difference in reputation
It would be simplistic to say that CBD is “the good cannabinoid” and THC “the bad one.” A serious approach must explain that these molecules have different pharmacological profiles, different uses, different risks, and different legal frameworks. In the context of informing the public, the priority is accuracy, caution, and transparency.
CBD, THC and the endocannabinoid system
The endocannabinoid system is a biological network present in the body. It includes endocannabinoids naturally produced by the body, receptors such as CB1 and CB2, and enzymes responsible for the synthesis and breakdown of these molecules. This system participates in several internal regulatory mechanisms.
THC binds strongly to certain receptors, particularly CB1, which explains its psychoactive effects. CBD, on the other hand, appears to act more indirectly. This distinction is fundamental to understanding why CBD does not produce the effects of THC.
To better understand this system, see:
The endocannabinoid system: biological role, function and link with CBD.
Why doesn't CBD get you high?
CBD doesn't produce a "high" because it doesn't activate CB1 receptors like THC does. The "high" associated with THC-rich cannabis is primarily due to THC's action on the central nervous system. CBD doesn't have this mechanism of action. That's why it's generally described as non-psychoactive.
The World Health Organization states that, in its pure form, cannabidiol does not appear to present any potential for abuse or addiction. Official source:
WHO — Questions and Answers on cannabidiol.
What are the effects of CBD?
The effects of CBD are the subject of much research and numerous user reports. However, in content intended for the general public, it is essential to remain cautious. CBD should not be presented as a treatment for stress, anxiety, pain, insomnia, or any other condition. Responsible information may discuss well-being, perceived relaxation, or scientific benefits, but it must avoid making medical claims.
The WHO has published a critical report on cannabidiol, often cited for its analysis of the profile of pure CBD. This report should not be interpreted as an argument for a general therapeutic promise, but it is an important source for understanding the profile of cannabidiol.
Read the WHO's critical report on cannabidiol.
CBD and relaxation
Many users associate CBD with a feeling of relaxation. This perception can vary depending on the individual, the product, the dosage, the spectrum, the presence of other cannabinoids, the context of use, and the quality of the product. There is no single answer.
CBD and sleep
Sleep is one of the most frequently researched topics regarding CBD. However, sleep quality depends on many factors: lifestyle, stress, diet, circadian rhythm, physical activity, screen time, environment, and overall health. CBD should not be presented as a guaranteed solution.
CBD and physical discomfort
Because the endocannabinoid system is involved in several regulatory mechanisms, some users are interested in CBD for its therapeutic benefits. However, it's important to distinguish between personal experience, scientific studies, and authorized medical claims. A CBD product sold to the public should not be presented as a pain reliever or anti-inflammatory.
What are the effects of THC?
THC is a psychoactive molecule. Its effects can include euphoria, altered sensory perception, impaired attention, altered perception of time, decreased coordination, drowsiness, anxiety, or confusion, depending on the individual, the dose, and the context. These effects explain why THC is subject to strict regulation.
THC can also have significant consequences for driving, activities requiring alertness, concentration, short-term memory, and safety. The effects can vary depending on the frequency of exposure, individual sensitivity, the composition of the product, and the environment.
THC and driving
THC is particularly concerning in the context of driving. In France, the presence of substances classified as narcotics during a roadside check can lead to severe penalties. Even when someone consumes a legal CBD product, the potential presence of trace amounts of THC should be taken seriously.
THC and risk perception
The normalization of THC can lead to an underestimation of its effects on alertness and behavior. This is why it is essential to clearly separate information about CBD from any discourse that promotes the psychotropic effects of THC.
CBD vs THC: a complete comparison chart
The table below summarizes the main differences between CBD and THC. It provides a quick overview of the key points but does not replace a complete regulatory analysis.
| Criteria | CBD | THC |
|---|---|---|
| Full name | Cannabidiol | Delta-9-tetrahydrocannabinol |
| Family | Cannabinoid | Cannabinoid |
| Origin | Cannabis sativa L. | Cannabis sativa L. |
| Psychotropic effect | No | Yes |
| Euphoric effect | Not wanted | Yes, depending on the dose and profile |
| Main interaction | Indirect and modulating action studied | Significant activation of CB1 receptors |
| Regulatory status | Allowed under certain conditions | Strictly regulated |
| Presence in compliant products | Main molecule sought in CBD products | Presence limited to the authorized regulatory threshold |
| Risk of screening | Possible if there are traces of THC in the product | Yes |
| Point of vigilance | Quality, analyses, interactions, traces of THC | Psychotropic effects, driving, legality, health |
CBD and THC: what does the law say in France and Europe?
The legality of CBD depends on several criteria: the origin of the hemp, its delta-9-THC content, the product category, its presentation, labeling, and intended use. In France, the decree of December 30, 2021, stipulates that the delta-9-THC content of hemp extracts and products containing them must not exceed 0.30%. Official source:
Decree of December 30, 2021, on Légifrance.
This 0.30% threshold is crucial, but it must not be misinterpreted. It is a regulatory threshold. The Council of State reiterated that this threshold is not a safety threshold, while deeming the general and absolute ban on the sale of flowers and leaves of cannabis varieties with a THC content below 0.30% disproportionate. Official source:
Council of State decision of December 29, 2022, available on Légifrance.
The CJEU's decision on CBD
The Court of Justice of the European Union has issued an important ruling in Case C-663/18, frequently cited in the CBD sector. This decision helped to distinguish cannabidiol from narcotics under European law, while still allowing Member States the option of taking justified and proportionate measures to protect public health.
Read the CJEU ruling C-663/18 on cannabidiol.
THC remains strictly regulated
The fact that CBD is permitted under certain conditions does not mean that THC is freely permitted. THC remains a strictly regulated psychoactive molecule. A product rich in THC does not become non-compliant simply because it also contains CBD. The actual composition of the product is therefore crucial.
CBD and THC flowers: understanding the legal threshold
CBD flowers are often the subject of confusion because their appearance can resemble that of THC-rich flowers. However, their chemical composition is different. A compliant CBD flower must meet the applicable regulatory THC threshold. It is precisely this analyzed composition that allows us to distinguish between a hemp flower with a low THC content and one high in THC.
The Council of State has overturned the general ban on the sale of cannabis flowers and leaves without narcotic properties below the regulatory threshold, deeming the ban disproportionate. The official statement specifies that CBD has no psychotropic effect and does not cause addiction. Source:
Council of State — annulment of the decree on CBD flowers and leaves.
Why appearance is never enough
A flower rich in CBD and a flower rich in THC can look similar. Smell, color, texture, or density cannot guarantee conformity. Only reliable analysis can determine the actual levels of THC, CBD, and other cannabinoids.
Importance of the certificate of analysis
A certificate of analysis verifies the composition of a batch. Ideally, it should indicate the CBD level, the THC level, the method of analysis, the laboratory, the date of testing, and the batch identification. For a consumer, this is an essential element of transparency.
CBD, THC, driving and testing: the key point of vigilance
Driving is one of the most important issues when discussing CBD and THC. Even when a CBD product complies with the regulatory threshold, it may contain traces of THC. These traces can cause problems during a drug test, depending on the frequency of use, the product's composition, individual sensitivity, and the testing methods used.
It is therefore essential to avoid overly reassuring statements. Saying that a CBD product is legal does not guarantee a complete absence of risk of detection. People who drive, operate machinery, hold positions of responsibility, or are subject to testing must be particularly careful.
Why can CBD cause problems while driving?
CBD itself is not THC. However, some CBD products may contain traces of THC. The risk, therefore, does not stem from a psychotropic effect of CBD comparable to THC, but from the possible presence of THC in certain products. This is why testing and transparency are essential.
Related article:
CBD, driving and THC testing: what you need to know.
Why testing is essential to distinguish between CBD and THC
Laboratory analysis is the only reliable way to know the true composition of a product. It allows for verification of CBD levels, THC levels, the presence of other cannabinoids, and, depending on the tests, the absence of contaminants. In a market where product quality can vary significantly, analysis is a cornerstone of transparency.
What should a serious analysis contain?
- The name or reference of the product analyzed.
- The batch number.
- The date of analysis.
- The laboratory that performed the test.
- The CBD level.
- The delta-9-THC level.
- The profile of other cannabinoids, if available.
- Contaminant controls, depending on the type of test.
Why a simple percentage of CBD is not enough
A product with a high CBD content is not automatically a quality product. Compliance with THC limits, product cleanliness, stability, hemp origin, and consistency between the label and analysis are equally important. A reputable product should be verifiable.
Read also:
Laboratory analyses: CBD, THC, contaminants and compliance.
Common mistakes to avoid when comparing CBD and THC
Comparing CBD and THC requires precision. Incorrect terminology can create false expectations, mislead consumers, or undermine the credibility of content.
Mistake #1: Saying that CBD is cannabis without nuance
CBD is a molecule found in Cannabis sativa L. It is not the plant itself. Cannabis can contain CBD, THC, and many other compounds. Precise terminology is essential.
Mistake #2: saying that CBD is always THC-free
Pure CBD contains no THC, but some CBD products may contain trace amounts of THC within the legal limit. This distinction is crucial for driving, testing, and compliance.
Mistake #3: Presenting CBD as a treatment
CBD should not be presented as a medicine in a sales or general information context. Claims of a cure or treatment should be avoided.
Mistake #4: Minimizing the effects of THC
THC is psychoactive. It can impair alertness and perception. Comparing it to CBD without mentioning these differences can create dangerous confusion.
Mistake #5: Forgetting the Novel Food framework
For food products or supplements containing CBD, the Novel Food framework may be relevant. Therefore, compliance does not depend solely on the THC level.
CBD vs THC FAQ
What is the main difference between CBD and THC?
The main difference is the psychoactive effect. THC can produce a euphoric effect and alter perception. CBD does not produce this "high".
Does CBD contain THC?
Pure CBD does not contain THC. However, some CBD products may contain traces of THC, within legal limits. Therefore, it is essential to check the analysis.
Is CBD legal in France?
CBD is permitted under certain conditions, particularly when hemp extracts and products containing them have a delta-9-THC content of less than or equal to 0.30%, in accordance with the decree of December 30, 2021.
Is THC legal?
THC remains strictly regulated in France. Its presence in hemp-derived products must comply with applicable regulatory thresholds. Products high in THC fall under a different framework.
Does CBD get you high?
No. CBD does not produce the euphoric effect associated with THC. This is a key difference between the two molecules.
Is it safe to drive after using CBD?
Caution is essential. Some CBD products may contain traces of THC, which can be detected during roadside checks. Drivers should avoid taking any risks.
Why is it necessary to request laboratory analyses?
The analyses make it possible to verify the actual composition of the product, including the CBD level, the THC level and the possible presence of contaminants.
Does CBD cancel out the effects of THC?
CBD and THC can interact in complex ways, but CBD should not be presented as a guarantee of canceling out the effects of THC. The product's composition, dosage, and individual profiles are all highly important factors.
Why do CBD and THC come from the same plant but have different effects?
Because they do not interact with the endocannabinoid system in the same way. THC strongly activates certain receptors involved in psychotropic effects, while CBD has a more indirect action.
Key takeaways about CBD vs THC
CBD and THC are two cannabinoids derived from Cannabis sativa L., but they should not be confused. CBD is non-psychoactive and permitted under certain conditions. THC is psychoactive and strictly regulated. This difference explains their legal status, their effects, the precautions to take, and how the products must be presented.
Reliable information should always emphasize that CBD does not produce a high, that it should not be presented as a medicine, that a CBD product may contain traces of THC, and that laboratory testing is essential to verify compliance. The 0.30% THC threshold is a regulatory limit, not an absolute guarantee of no risk in all situations.
Understanding the difference between CBD and THC is therefore the foundation of a responsible approach to cannabidiol. This distinction protects the consumer, clarifies the legal framework, and improves the quality of information.
Recommended next article:
CBD legal in France and Europe: complete regulatory framework.